Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers

CompletedOBSERVATIONAL
Enrollment

181

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

October 25, 2021

Study Completion Date

October 25, 2021

Conditions
Healthy
Interventions
DIAGNOSTIC_TEST

TEG 6s Citrated K, KH, RTH, and FFH Cartridge

The TEG® 6s uses the Global Hemostasis with Heparin Neutralization (HN) Cartridge to test the hemostasis properties of citrated blood samples using four different assays/reagents simultaneously, one in each of the four cartridge channels.

DIAGNOSTIC_TEST

Clauss Fibrinogen

"Fibrinogen, also known as Factor I, is a plasma protein that can be transformed by thrombin into a fibrin gel (the clot). Fibrinogen is synthesized in the liver and circulates in the plasma as a disulfide-bonded dimer of 3 subunit chains. The biological half-life of plasma fibrinogen is 3 to 5 days."

Trial Locations (3)

60153

Cardiovascular Research Institute - Loyola University Chicago Health Sciences, Maywood

70118

Louisiana Coagulation / Machaon Division, New Orleans

94609

Machaon Diagnostics, Oakland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Machaon Diagnostics

INDUSTRY

collaborator

ClinStatDevice

UNKNOWN

lead

Haemonetics Corporation

INDUSTRY